Target Healthcare REIT (LSE:THRL) ROC (Joel Greenblatt) %: % (As of Dec. 2025)


LSE:THRL Target Healthcare REIT PLC LSE:THRL
39 GF Score
Price £1.11
GF Value £0.88
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Target Healthcare REIT ROC (Joel Greenblatt) %?

Target Healthcare REIT LSE:THRL -0.90% 39 ROC (Joel Greenblatt) % is % as of Dec. 2025. GuruFocus rates LSE:THRL with a GF Score™ of 39/100 and a GF Value™ of £0.88 (Modestly Overvalued). The stock has 7 warning signs investors should review. Among 586 REITs companies, Target Healthcare REIT ranks worse than 170648.29% on this metric.

ROC (Joel Greenblatt) % does not apply to banks and insurance companies.

LSE:THRL
39GF Score
Target Healthcare REIT PLC LSE:THRL
ROC (Joel Greenblatt) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a ROC (Joel Greenblatt) % of % mean?
Target Healthcare REIT (LSE:THRL) has a ROC (Joel Greenblatt) % of % as of Dec. 2025. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Target Healthcare REIT and its competitors. According to the industry distribution chart, Target Healthcare REIT ranks #999999 out of 586 companies in the REITs industry.
Is Target Healthcare REIT's ROC (Joel Greenblatt) % too high?
Target Healthcare REIT's current ROC (Joel Greenblatt) % is %. Based on the distribution chart, Target Healthcare REIT ranks #999999 out of 586 companies in the REITs industry, which is in the bottom quartile relative to peers. Overall, Target Healthcare REIT has a GF Score™ of 39/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Target Healthcare REIT's ROC (Joel Greenblatt) % compare to WELL and VTR?
According to the REITs industry distribution chart, Target Healthcare REIT ranks #999999 out of 586 companies for ROC (Joel Greenblatt) %. This places Target Healthcare REIT in the lower half of its industry. The industry median ROC (Joel Greenblatt) % is 180.65. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a REITs company?
The median ROC (Joel Greenblatt) % among REITs companies is 180.65, based on 586 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Target Healthcare REIT and its competitors. For the REITs industry, the median ROC (Joel Greenblatt) % is 180.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Target Healthcare REIT's current ROC (Joel Greenblatt) % is %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Target Healthcare REIT stock overvalued right now?
Based on GuruFocus' analysis, Target Healthcare REIT (LSE:THRL) is currently considered Modestly Overvalued. The stock's GF Value™ is £0.88, compared to a current price of £1.11 — trading 25.7% above its estimated fair value. The current ROC (Joel Greenblatt) % is %. Target Healthcare REIT's overall GF Score™ is 39/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Target Healthcare REIT (LSE:THRL), the current ROC (Joel Greenblatt) % is % as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Target Healthcare REIT (LSE:THRL) Overvalued in 2026?

Based on GuruFocus' analysis, Target Healthcare REIT stock appears to be overvalued. The current stock price of £1.11 is trading 25.7% above its estimated GF Value™ of £0.88. GuruFocus considers Target Healthcare REIT to be Modestly Overvalued.

Key valuation signals for LSE:THRL:

  • ROC (Joel Greenblatt) %: %
  • GF Value™: £0.88 vs. price of £1.11 (25.7% above fair value)
  • GF Score™: 39/100 with 7 warning signs

No single metric tells the full story. See the LSE:THRL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Target Healthcare REIT Business Description

Industry Real EstateREITs
Address 69 Old Broad Street, Level 4, Dashwood House, London, GBR, EC2M 1QS
Target Healthcare REIT PLC is an investment company that acts as a long-term investor in care homes in the United Kingdom. The investment objective of the company is to provide shareholders with an attractive level of income together with the potential for capital and income growth from investing in a diversified portfolio of freehold and long-leasehold care homes, which are let to care home operators, and other healthcare assets in the United Kingdom.
39GF Score

Get the complete analysis for LSE:THRL

ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£1.11
Price
£0.88
GF Value